Radiology, Vol 201, 531-539, Copyright © 1996 by Radiological Society of North America

ARTICLES

Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging

H Hawighorst, PG Knapstein, W Weikel, MV Knopp, U Schaeffer, G Brix, M Essig, U Hoffmann, I Zuna, S Schonberg and G van Kaick
Department of Radiology Diagnostics and Therapy, German Cancer Research Center, Heidelberg, Germany.

PURPOSE: To stage advanced cervical carcinoma with conventional or pharmacokinetic magnetic resonance (MR) imaging by correlating imaging findings with whole-mount specimens and histopathologic findings. MATERIALS AND METHODS: Twenty-six adult patients with primary cervical cancer (stages IIB-IVA) underwent T2-weighted turbo spin-echo (SE) MR imaging; gadolinium-enhanced, T1-weighted SE MR imaging; and gadolinium- enhanced, saturation-recovery, turbo fast low-angle shot MR imaging. All imaging findings were correlated with the whole-mount specimens and histopathologic findings. Signal intensity changes versus time were analyzed by using a pharmacokinetic model and parameter values displayed as a color-coded overlay. RESULTS: Histopathologic stages were IIB (n = 9), IIIB (n = 1), and IVA (n = 16). The overall accuracy for tumor staging was 73% for T2-weighted, 81% for T1-weighted, and 92% for pharmacokinetic MR imaging. Pharmacokinetic MR imaging was accurate (90%) in the diagnosis of tumor extension into the bladder and/or rectal wall but inaccurate (69%) in that of parametrial invasion. T2- weighted images were most accurate (86%) in the assessment of parametrial tumor extension but less accurate (69%) in that of bladder or rectal invasion. CONCLUSION: T2-weighted turbo SE images are still superior to contract medium-enhanced T1-weighted SE or pharmacokinetic MR images in the diagnosis of parametrial infiltration by uterine cervical carcinoma. However, pharmacokinetic MR imaging is a promising method for demonstrating and staging IVA disease.

This article has been cited by other articles:

				H. J. Michaely, H. Kramer, N. Oesingmann, K.-P. Lodemann, M. F. Reiser, and S. O. Schoenberg Semiquantitative Assessment of First-Pass Renal Perfusion at 1.5 T: Comparison of 2D Saturation Recovery Sequences With and Without Parallel Imaging Am. J. Roentgenol., April 1, 2007; 188(4): 919 - 926. [Abstract] [Full Text] [PDF]

				H. J. Michaely, S. O. Schoenberg, N. Oesingmann, C. Ittrich, C. Buhlig, D. Friedrich, A. Struwe, J. Rieger, C. Reininger, W. Samtleben, et al. Renal Artery Stenosis: Functional Assessment with Dynamic MR Perfusion Measurements--Feasibility Study Radiology, February 1, 2006; 238(2): 586 - 596. [Abstract] [Full Text] [PDF]

				H. Kaur, P. M. Silverman, R. B. Iyer, C. F. Verschraegen, P. J. Eifel, and C. Charnsangavej Diagnosis, Staging, and Surveillance of Cervical Carcinoma Am. J. Roentgenol., June 1, 2003; 180(6): 1621 - 1631. [Full Text] [PDF]

				N. J. Fischbein, S. M. Noworolski, R. G. Henry, M. J. Kaplan, W. P. Dillon, and S. J. Nelson Assessment of Metastatic Cervical Adenopathy Using Dynamic Contrast-Enhanced MR Imaging AJNR Am. J. Neuroradiol., March 1, 2003; 24(3): 301 - 311. [Abstract] [Full Text] [PDF]

				Y. Yamashita, T. Baba, Y. Baba, R. Nishimura, S. Ikeda, M. Takahashi, H. Ohtake, and H. Okamura Dynamic Contrast-enhanced MR Imaging of Uterine Cervical Cancer: Pharmacokinetic Analysis with Histopathologic Correlation and Its Importance in Predicting the Outcome of Radiation Therapy Radiology, September 1, 2000; 216(3): 803 - 809. [Abstract] [Full Text]

				P. H. Lai, C. F. Yang, H. B. Pan, M. T. Wu, S. T. Chu, L. P. Ger, W. C. Huang, C. C. Hsu, and C. N. Lee Recurrent Inverted Papilloma: Diagnosis with Pharmacokinetic Dynamic Gadolinium-EnhancedMR Imaging AJNR Am. J. Neuroradiol., September 1, 1999; 20(8): 1445 - 1451. [Abstract] [Full Text]